Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial

European Journal of Heart Failure

Volumn 9, Issue 4, 2007, Pages 397-402

  Cicoira, Mariantonietta ^a   Maggioni, Aldo Pietro ^b   Latini, Roberto ^c   Barlera, Simona ^c   Carretta, Elisa ^c   Janosi, Andras ^d   Soler Soler, Jordi ^e   Anand, Inder ^f   Cohn, Jay N ^f  

^a UNIVERSITY OF VERONA   (Italy)

^b ANMCO RESEARCH CENTER   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d 3rd Department of Internal Medicine   (Hungary)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Body mass index; Heart failure; Prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; VALSARTAN;

ADULT; AGED; ARTICLE; BODY MASS; CAUSE OF DEATH; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART FAILURE; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; POST HOC ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK; UNDERWEIGHT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DISEASE PROGRESSION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MORTALITY; OBESITY; OVERWEIGHT; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL;

EID: 33947356644     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.10.016     Document Type: Article

References (27)

1. Diehr P., Bild D.E., Harris T.B., Duxbury A., Siscovick D., and Rossi M. Body mass index and mortality in nonsmoking older adults: the Cardiovascular Health Study. Am J Public Health 88 (1998) 623-629
2. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., and Heath C.W. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341 (1999) 1097-1105
3. Manson J.E., Willett W.C., Stampfer M.J., et al. Body weight and mortality among women. N Engl J Med 333 (1995) 677-685
4. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
5. Willett W.C., Dietz W.H., and Colditz G.A. Guidelines for healthy weight. N Engl J Med 341 (2003) 427-434
6. De Backer G., Ambrosioni E., Broch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 10 (2003) S1-S78
7. Remme W.J., and Swedberg K. Task Force for the Diagnosis and Treatment of Chronic Heart Failure. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
8. Anker S., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in heart failure. Lancet 349 (1997) 1050-1053
9. Davos C.H., Doehner W., Rauchhaus M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9 (2003) 29-35
10. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., Woo M.A., and Tillisch J.H. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38 (2001) 789-795
11. Curtis J.P., Selter J.G., Wang Y., et al. Body mass index and outcomes in patients with heart failure. Arch Intern Med 165 (2005) 55-61
12. Maggioni A.P., Opasich C., Anand I., et al. Anemia in patients with heart failure: prevalence prognostic role in a controlled trial and in clinical practice. J Card Fail 11 (2005) 91-98
13. Cohn J., Tognoni G., Glazer R.D., Spormann D., and Hester A. Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of Valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic Congestive Heart Failure. J Card Fail 5 (1999) 155-160
14. Cohn J., Tognoni G., and For the Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker Valsartan in chronic heart failure. N Engl J Med 345 (2001) 1667-1675
15. Allison D.B., Gallagher D., Heo M., Pi-Sunyer F.X., and Hehmsfield S.B. Body mass index and all-cause mortality among people age 70 and over: the longitudinal study of aging. Int J Obes Relat Metab Disord 21 (1997) 424-431
16. Lee I.M., Manson J.E., Hennekens C.H., and Paffenbarger Jr. R.S. Body weight and mortality: a 27-year follow-up of middle-aged men. JAMA 270 (1993) 2823-2828
17. Lavie C.J., Osman A.F., Milani R.V., and Mehra M.R. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91 (2003) 891-894
18. Gurm H.S., Whitlow P.L., Kip K.E., and The BARI Investigators. The impact of body mass index on short- and long-term outcome in patients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 39 (2002) 834-840
19. Gruberg L., Weissman N.J., Waksman R., et al. The impact of obesity on the short-term and long-term outcomes after percutaneous intervention: the obesity paradox?. J Am Coll Cardiol 39 (2002) 578-584
20. Somes G.W., Kritchevsky, Shorr R.I., Pahor M., and Applegate W.B. Body mass index, weight change, and death in older adults. The systolic hypertension in the elderly program. Am J Epidemiol 156 (2002) 132-138
21. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
22. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
23. Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96 (1997) 526-534
24. Aquilani R., Opasich C., Verri M., et al. Is nutritional intake adequate in chronic heart failure patients?. J Am Coll Cardiol 42 (2003) 1218-1223
25. Cicoira M., Jankowska E., Doehner W., et al. Body composition and survival in 511 chronic heart failure patients. Eur Heart J 25 (2004) 365 [Abstract]
26. Anker S.D., Negassa A., Coats A.J., et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361 (2003) 1077-1083
27. Anker S.D., Coats A.J.S., Roecker E.B., Scherhag A., and Packer M. Does carvedilol prevent and reverse cardiac cachexia in patients with severe heart failure? Results of the COPERNICUS study. Eur Heart J 23 (2002) 394 [Abstract]